Bicara Therapeutics BCAX
NASDAQ BCAX
$18.53 -0.08 (-0.43%)
As of: Oct 1, 2026 · 11:38 AM EDT

Bicara Therapeutics (BCAX) Preferred Stock Liabilities (2023 - 2024)

Updated

Bicara Therapeutics' Preferred Stock Liabilities came in at $367.28 million for Q2 2024, unchanged from the prior quarter.

Analysis

Bicara Therapeutics (BCAX) Preferred Stock Liabilities (2023 - 2024) Analysis & Trends

Going back to Q3 2023, Bicara Therapeutics' Preferred Stock Liabilities data covers 4 quarters.

  • Business Quant data shows BCAX's Preferred Stock Liabilities at $367.28 million (Q1 2024), $367.28 million (Q4 2023) and $166.53 million (Q3 2023) in the three quarters before Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Bicara Therapeutics 1.23 Bn 1.23 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 367.28 Mn
Mar 31, 2024 367.28 Mn
Dec 31, 2023 367.28 Mn
Sep 30, 2023 166.53 Mn
API Access

Bicara Therapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=BCAX&period=max&api_key=YOUR_API_KEY